MedTrace Logo

Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)

NCT03365076 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2023-01-09

No results posted yet for this study

Summary

Previous research into metabolic and hypoxic markers has found evidence of preclinical impact of exercise on prostate tumor blood flow and oxygenation in rodents . As radiotherapy is a frequently used and effective therapy for and that sufficient oxygenation is decisive to the effect of radiotherapy, an underlying hypothesis that aerobic exercise might improve treatment efficacy of radiotherapy in prostate cancer is put forward. This study has a potential challenging intervention, but a potential very high gain as it includes active patient participation to significantly improve outcome of radical radiotherapy.

Conditions

Interventions

OTHER

Physical activity

Aerobic physical activity as stated in Arm A

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER

  • University of Tromso

    collaborator OTHER

  • Northern Health Authority

    collaborator OTHER_GOV

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Sigve Andersen, MD, PhD · UNN HF Tromsø

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2023-01-05
Completion
2023-01-05

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03365076 on ClinicalTrials.gov